Suppr超能文献

控制神经母细胞瘤生长的新方法。

New methods to control neuroblastoma growth.

作者信息

Dent Paul

机构信息

Department of Biochemistry and Molecular Biology; Massey Cancer Center; Virginia Commonwealth University; Richmond, VA USA.

出版信息

Cancer Biol Ther. 2014 May;15(5):481-2. doi: 10.4161/cbt.28465. Epub 2014 Mar 11.

Abstract

Downstream of growth factor receptors, signaling by the phosphoinositide 3 kinase (PI3K) pathway is known to play an important role in the growth and survival of many tumor types. The PI3K pathway simplistically comprises PI3K itself, followed by PDK-1, then AKT and finally glycogen synthase kinase 3 (GSK3). PI3K/AKT signaling promotes increased GSK3 phosphorylation, that is associated with reduced GSK3 activity. There are two isoforms of GSK3, GSK3α and GSK3β, which have a high degree of sequence homology. GSK3 plays a role not only in the regulation of glycogen synthase activity but in the expression of multiple other proteins that play a role in cancer biology, including cyclins and anti-apoptotic proteins.

摘要

在生长因子受体的下游,磷酸肌醇3激酶(PI3K)信号通路在多种肿瘤类型的生长和存活中发挥重要作用。PI3K信号通路简单地包括PI3K本身,接着是PDK-1,然后是AKT,最后是糖原合酶激酶3(GSK3)。PI3K/AKT信号传导促进GSK3磷酸化增加,这与GSK3活性降低有关。GSK3有两种亚型,GSK3α和GSK3β,它们具有高度的序列同源性。GSK3不仅在糖原合酶活性的调节中起作用,而且在多种其他在癌症生物学中起作用的蛋白质的表达中起作用,包括细胞周期蛋白和抗凋亡蛋白。

相似文献

1
New methods to control neuroblastoma growth.
Cancer Biol Ther. 2014 May;15(5):481-2. doi: 10.4161/cbt.28465. Epub 2014 Mar 11.
2
Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growth.
Cancer Biol Ther. 2014 May;15(5):510-5. doi: 10.4161/cbt.28015. Epub 2014 Feb 12.
3
Identification of glycogen synthase kinase 3α as a therapeutic target in melanoma.
Pigment Cell Melanoma Res. 2013 Nov;26(6):886-99. doi: 10.1111/pcmr.12156. Epub 2013 Sep 19.
4
Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418.
J Biol Chem. 2003 Nov 14;278(46):45937-45. doi: 10.1074/jbc.M306268200. Epub 2003 Aug 19.
5
GSK3β suppression inhibits MCL1 protein synthesis in human acute myeloid leukemia cells.
J Cell Physiol. 2021 Jan;236(1):570-586. doi: 10.1002/jcp.29884. Epub 2020 Jun 22.
6
Potential therapeutic effect of glycogen synthase kinase 3beta inhibition against human glioblastoma.
Clin Cancer Res. 2009 Feb 1;15(3):887-97. doi: 10.1158/1078-0432.CCR-08-0760.
8
Inhibition of glycogen synthase kinase-3 increases the cytotoxicity of enzastaurin.
J Invest Dermatol. 2011 Jul;131(7):1442-9. doi: 10.1038/jid.2011.70. Epub 2011 Apr 7.
9
GSK3α/β: A Novel Therapeutic Target for Neuroendocrine Tumors.
Neuroendocrinology. 2018;106(4):335-351. doi: 10.1159/000481887. Epub 2017 Oct 2.
10
Inhibition of GSK-3β reverses the pro-apoptotic effect of proadifen (SKF-525A) in HT-29 colon adenocarcinoma cells.
Toxicol In Vitro. 2012 Sep;26(6):775-82. doi: 10.1016/j.tiv.2012.05.014. Epub 2012 Jun 7.

引用本文的文献

本文引用的文献

1
Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growth.
Cancer Biol Ther. 2014 May;15(5):510-5. doi: 10.4161/cbt.28015. Epub 2014 Feb 12.
2
Sequential dosing in chemosensitization: targeting the PI3K/Akt/mTOR pathway in neuroblastoma.
PLoS One. 2013 Dec 31;8(12):e83128. doi: 10.1371/journal.pone.0083128. eCollection 2013.
3
Identification of glycogen synthase kinase 3α as a therapeutic target in melanoma.
Pigment Cell Melanoma Res. 2013 Nov;26(6):886-99. doi: 10.1111/pcmr.12156. Epub 2013 Sep 19.
4
Sorafenib/regorafenib and phosphatidyl inositol 3 kinase/thymoma viral proto-oncogene inhibition interact to kill tumor cells.
Mol Pharmacol. 2013 Oct;84(4):562-71. doi: 10.1124/mol.113.088005. Epub 2013 Jul 22.
5
Activator or inhibitor? GSK-3 as a new drug target.
Biochem Pharmacol. 2013 Jul 15;86(2):191-9. doi: 10.1016/j.bcp.2013.04.022. Epub 2013 May 2.
7
The neuroprotective effect of the GSK-3β inhibitor and influence on the extrinsic apoptosis in the ALS transgenic mice.
J Neurol Sci. 2012 Sep 15;320(1-2):1-5. doi: 10.1016/j.jns.2012.05.038. Epub 2012 Jun 12.
8
Recent advances in neuroblastoma.
N Engl J Med. 2010 Jun 10;362(23):2202-11. doi: 10.1056/NEJMra0804577.
9
Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma.
Br J Cancer. 2009 Dec 15;101(12):2005-14. doi: 10.1038/sj.bjc.6605437. Epub 2009 Nov 17.
10
Phosphoinositide-regulated kinases and phosphoinositide phosphatases.
Chem Rev. 2001 Aug;101(8):2365-80. doi: 10.1021/cr000091i.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验